| scholarly article | Q13442814 |
| P50 | author | Shou-Jiang Gao | Q41839530 |
| Shahin Rafii | Q56530701 | ||
| Dirk Dittmer | Q71109132 | ||
| Enrique A Mesri | Q89475188 | ||
| Lucas E Cavallin | Q118482231 | ||
| P2093 | author name string | Chiara Chiozzini | |
| Krista M D La Perle | |||
| Andrea T Hooper | |||
| Pilar Eroles | |||
| Zahra Asgari | |||
| Loïc Vincent | |||
| Agata D'Agostino Mutlu | |||
| Chelsey Hilsher | |||
| Elda M Duran | |||
| P2860 | cites work | Aids-related malignancies | Q22251046 |
| Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors | Q28190673 | ||
| Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration | Q28207902 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| The tumor microenvironment controls primary effusion lymphoma growth in vivo | Q28272290 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Identifying differentially expressed genes using false discovery rate controlling procedures | Q29615200 | ||
| KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice | Q30440843 | ||
| Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells | Q33623056 | ||
| Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene | Q33784194 | ||
| Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. | Q33817882 | ||
| Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures | Q33841987 | ||
| Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen | Q33859518 | ||
| Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma | Q33889051 | ||
| Cellular senescence: mitotic clock or culture shock? | Q34019131 | ||
| Angiogenesis assays: problems and pitfalls | Q34146311 | ||
| Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR | Q34340317 | ||
| Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. | Q34408877 | ||
| Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse | Q34471059 | ||
| The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells | Q34512207 | ||
| Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. | Q34548882 | ||
| The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome | Q34693731 | ||
| Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma | Q35131811 | ||
| Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. | Q35773499 | ||
| Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. | Q35774050 | ||
| Advances in the pathobiology and treatment of Kaposi sarcoma | Q35864760 | ||
| Evidence for multiclonality in multicentric Kaposi's sarcoma | Q36173459 | ||
| Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. | Q36369648 | ||
| Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice | Q36375588 | ||
| KSHV infection and the pathogenesis of Kaposi's sarcoma | Q37014777 | ||
| Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation | Q37568044 | ||
| Inhibition of p53 tumor suppressor by viral interferon regulatory factor | Q39606488 | ||
| Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis | Q39683622 | ||
| De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells | Q39748116 | ||
| Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | Q39877852 | ||
| Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo | Q40287215 | ||
| The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. | Q40333151 | ||
| Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. | Q40364647 | ||
| ORF36 protein kinase of Kaposi's sarcoma herpesvirus activates the c-Jun N-terminal kinase signaling pathway. | Q40537026 | ||
| Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection | Q40598301 | ||
| The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter | Q40811288 | ||
| Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus | Q41050488 | ||
| Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines | Q41088030 | ||
| Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. | Q41125455 | ||
| Angiogenesis and angiogenesis inhibition: an overview | Q41322520 | ||
| Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. | Q42814766 | ||
| G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator | Q42833351 | ||
| KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway | Q42834462 | ||
| Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. | Q44277985 | ||
| Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls | Q45789684 | ||
| Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus | Q47675996 | ||
| Presenilin-1 detection in brain neurons and FOXp3 in peripheral blood mononuclear cells: normalizer gene selection for real time reverse transcriptase pcr using the DeltaDeltaCt method | Q48842056 | ||
| Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. | Q53347753 | ||
| Kaposi's sarcoma-associated herpesvirus. | Q53947567 | ||
| Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus | Q56794246 | ||
| Vascular Endothelial Growth Factor-C (VEGF-C) and its Receptors KDR and flt-4 are Expressed in AIDS-Associated Kaposi’s Sarcoma | Q57382283 | ||
| Monoclonal Origin of Multicentric Kaposi's Sarcoma Lesions | Q58366797 | ||
| KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma | Q58907143 | ||
| Isolation and Angiogenesis by Endothelial Progenitors in the Fetal Liver | Q60446293 | ||
| Gene amplification and multiple mutations of the K-ras oncogene in Kaposi's sarcoma | Q72159224 | ||
| Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays | Q73344152 | ||
| Bcl-2 and p53 immunoprofile in Kaposi's sarcoma | Q74609153 | ||
| The enigmas of Kaposi's sarcoma | Q77752067 | ||
| Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes | Q78860218 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 245-258 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Cancer Cell | Q280018 |
| P1476 | title | In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma | |
| P478 | volume | 11 |
| Q42285748 | A CreER-based random induction strategy for modeling translocation-associated sarcomas in mice. |
| Q36415707 | A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis |
| Q42624833 | A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity |
| Q45746573 | Accumulation of dephosphorylated 4EBP after mTOR inhibition with rapamycin is sufficient to disrupt paracrine transformation by the KSHV vGPCR oncogene. |
| Q36364238 | Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression |
| Q45399715 | An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia. |
| Q28750291 | Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus |
| Q34980236 | Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma |
| Q36818306 | Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059. |
| Q36559926 | CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming |
| Q42425087 | Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium |
| Q26766493 | Co-infections and Pathogenesis of KSHV-Associated Malignancies |
| Q40020777 | Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators |
| Q39323923 | Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone |
| Q35780222 | Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV |
| Q36340825 | Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
| Q36890993 | Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma |
| Q34059058 | Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma |
| Q36710457 | Endolysosomal trafficking of viral G protein-coupled receptor functions in innate immunity and control of viral oncogenesis. |
| Q33369078 | Endothelial cells support persistent gammaherpesvirus 68 infection |
| Q34472101 | Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines |
| Q36018434 | HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice |
| Q37711147 | Human viral oncogenesis: a cancer hallmarks analysis |
| Q34795543 | Immune Evasion by Kaposi‘s Sarcoma-Associated Herpesvirus |
| Q36061450 | Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose |
| Q33585787 | Increased tumorigenicity of cells carrying recombinant human herpesvirus 8. |
| Q38048861 | Instigation of Notch signaling in the pathogenesis of Kaposi's sarcoma-associated herpesvirus and other human tumor viruses |
| Q92875825 | Interactions between Autophagy and DNA Viruses |
| Q42431495 | Jay and Jeanie Schottenstein prize in cardiovascular science: predicting cardiovascular illnesses for the 21(st) century, and the unpredictable.. |
| Q40718646 | KSHV Down-regulates Tropoelastin in Both an in-vitro and in-vivo Kaposi's Sarcoma Model. |
| Q41662283 | KSHV and the Role of Notch Receptor Dysregulation in Disease Progression |
| Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
| Q33509506 | KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia |
| Q35079842 | KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways |
| Q50099317 | KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite |
| Q28080937 | KSHV reactivation and novel implications of protein isomerization on lytic switch control |
| Q26742030 | KSHV-Mediated Angiogenesis in Tumor Progression |
| Q89475191 | KSHV-induced ligand mediated activation of PDGF receptor-alpha drives Kaposi's sarcomagenesis |
| Q45911996 | KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi’s sarcoma. |
| Q92381594 | Kaposi Sarcoma-Associated Herpesvirus Glycoprotein H Is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types |
| Q94012444 | Kaposi sarcoma |
| Q40046587 | Kaposi sarcoma herpesvirus pathogenesis. |
| Q34594736 | Kaposi sarcoma in transplantation |
| Q36486893 | Kaposi sarcoma-associated herpesvirus promotes tumorigenesis by modulating the Hippo pathway. |
| Q38943741 | Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy |
| Q92376588 | Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis |
| Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
| Q28221605 | Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells |
| Q40503391 | Kaposi's sarcoma herpesvirus oncogenesis is a notch better in 3D. |
| Q47788484 | Kaposi's sarcoma virally encoded, G-protein-coupled receptor: a paradigm for paracrine transformation. |
| Q28473623 | Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity |
| Q42141115 | Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells |
| Q84021334 | Kaposi's sarcoma-associated herpesvirus infection of endothelial progenitor cells impairs angiogenic activity in vitro |
| Q42221687 | Kaposi's sarcoma-associated herpesvirus infection of human bone-marrow-derived mesenchymal stem cells and their angiogenic potential. |
| Q36540187 | Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency |
| Q26865827 | Keeping it quiet: chromatin control of gammaherpesvirus latency |
| Q36405877 | Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor. |
| Q57462211 | Mast Cell Activation and KSHV Infection in Kaposi Sarcoma |
| Q26860203 | Modeling human endothelial cell transformation in vascular neoplasias |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q33624377 | Modulation of chemokine activity by viruses. |
| Q39173806 | Modulation of oncogenic signaling networks by Kaposi's sarcoma-associated herpesvirus |
| Q90319823 | Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q34663095 | Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS |
| Q33819076 | Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases |
| Q38160783 | Molecular studies and therapeutic targeting of Kaposi's sarcoma herpesvirus (KSHV/HHV-8) oncogenesis |
| Q39435120 | Multiple defects, including premature apoptosis, prevent Kaposi's sarcoma-associated herpesvirus replication in murine cells |
| Q33508240 | Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection |
| Q92278120 | PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment |
| Q33317285 | Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus |
| Q33432690 | Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. |
| Q37525707 | Productively infected murine Kaposi's sarcoma-like tumors define new animal models for studying and targeting KSHV oncogenesis and replication |
| Q35673143 | Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice |
| Q99591124 | Regulation of KSHV Latency and Lytic Reactivation |
| Q37590325 | Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus |
| Q39659259 | Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor. |
| Q30439948 | Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus |
| Q39942917 | Studying Rac1-induced tumorigenesis suggests antioxidants may help prevent and treat Kaposi's sarcoma |
| Q35546590 | Systemic expression of Kaposi sarcoma herpesvirus (KSHV) Vflip in endothelial cells leads to a profound proinflammatory phenotype and myeloid lineage remodeling in vivo |
| Q34845533 | Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. |
| Q54245037 | The Immunomodulatory Capacity of an Epstein-Barr Virus Abortive Lytic Cycle: Potential Contribution to Viral Tumorigenesis. |
| Q33872257 | The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation |
| Q35108526 | The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity. |
| Q38248404 | The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma |
| Q99631024 | Unbiased Screening of Activated Receptor Tyrosine Kinases (RTKs) in Tumor Extracts Using a Mouse Phospho-RTK Array Kit |
| Q55618701 | VEGF Upregulation in Viral Infections and Its Possible Therapeutic Implications. |
| Q34237734 | Viral profiling identifies multiple subtypes of Kaposi's sarcoma. |
| Q80526283 | [Humanes herpesvirus 8 (HHV-8) and Kaposi sarcoma] |
Search more.